Retraction | Open | Published:

Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model

Retraction Note to:

Cell Death and Disease (2016)7:e2094

https://doi.org/10.1038/cddis.2016.11 published online 11 February 2016

This article has been retracted at the request of the authors. After publication, the authors found that in Fig. 2B-a the first two images in the third row partly overlapped and that there is also overlap between the fourth and fifth images in the second row. The two images were taken from two adjacent wells, treated by ZA 0.3 μM-CM or ZA 0.75 μM-CM, with or without PL 1.25 μM. This overlap may have been caused by mishandling in the imaging process when the authors made microscope observations and so the findings are no longer reliable. All authors agree to this retraction.

Author information

Correspondence to T. T. Tang.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article